Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.12
-0.2700-1.65%
Pre-market: 16.850.7300+4.53%09:24 EDT
Volume:22.31M
Turnover:365.08M
Market Cap:18.49B
PE:-11.12
High:16.71
Open:16.43
Low:16.12
Close:16.39
Loading ...

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

Benzinga
·
10 Jan

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

Zacks
·
09 Jan

Catalyst Pharmaceuticals Reaches Settlement Deal With Teva Over Firdapse Patent Litigation

MT Newswires Live
·
09 Jan

Catalyst Pharmaceuticals in Settlement With Teva of Firdapse Patent Litigation

Dow Jones
·
09 Jan

BRIEF-Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE (Amifampridine) Patent Litigation With Teva Pharmaceuticals

Reuters
·
09 Jan

Catalyst Pharmaceuticals Announces Settlement of Firdapse® (Amifampridine) Patent Litigation With Teva Pharmaceuticals

THOMSON REUTERS
·
09 Jan

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

GlobeNewswire
·
09 Jan

Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug

Benzinga
·
06 Jan

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

Insider Monkey
·
03 Jan

Vantage Drilling International Ltd. Announces Creation of Totalenergies and Vantage Joint Venture Entity

GlobeNewswire
·
02 Jan

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

Insider Monkey
·
28 Dec 2024

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Insider Monkey
·
24 Dec 2024

Teva put volume heavy and directionally bearish

TIPRANKS
·
24 Dec 2024

Weekly Winners | Teva Soars 34%; Birkenstock Rallies 10%; Palantir, Li Auto Gain 6%

Tiger Newspress
·
22 Dec 2024

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey
·
21 Dec 2024

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

Zacks
·
20 Dec 2024

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

Insider Monkey
·
19 Dec 2024

Stock Track | Teva Pharmaceutical Soars 5% on Positive Study Data For Investigational IBD Drug

Stock Track
·
19 Dec 2024

Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says

MT Newswires Live
·
19 Dec 2024

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $25 From $23, Keeps Buy Rating

MT Newswires Live
·
18 Dec 2024